Logo for Magnasense

Magnasense Investor Relations Material

Latest events

Logo for Magnasense

Q3 2024

15 Nov, 2024
Logo for Magnasense

Q2 2024

23 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Magnasense

Access all reports
Magnasense, a diagnostic company, develops and commercializes tests to follow the dosage of biological drugs. Magnasense's main product is the Oncolynx®, a urine test to be used with treatment of colorectal cancer patients. The test measures the levels of the drug in the bloodstream. This helps physicians optimize the dosage to achieve effective and safe treatment of cancer with biological drugs. The company was incorporated in 2019 and is based in Lund, Sweden.